Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-16-122623)

Filing Details

Accession Number:: 0001209191-16-122623
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-05-23 16:34:35
Reporting Period:: 2016-05-20

Filing Date:: 2016-05-23
Accepted Time:: 2016-05-23 16:34:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1610618	Cidara Therapeutics Inc.	CDTX	Biological Products, (No Disgnostic Substances) (2836)	461537286

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1638943	Kevin Forrest	6310 Nancy Ridge Drive Suite 101 San Diego CA 92121	Coo & Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-05-20	4,356	$11.53	58,253	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Represents a weighted average purchase price per share. These shares were purchased in multiple transactions at prices ranging from $11.46 to $11.62.
Includes 2,178 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on 5/20/2016.